These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38507997)

  • 1. Bis-arylidene oxindoles for colorectal cancer nanotherapy.
    Bhattacharyya T; Mishra T; Das D; Adhikari SS; Banerjee R
    Bioorg Chem; 2024 May; 146():107294. PubMed ID: 38507997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic lipid-conjugated bis-arylidene oxindole derivatives as broad-spectrum breast cancer-selective therapeutics.
    Yousuf M; Sridharan K; Mishra T; Mahadik NS; Banerjee R; Adhikari SS
    Bioorg Chem; 2023 Apr; 133():106395. PubMed ID: 36753964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bis-arylidene oxindoles as anti-breast-cancer agents acting via the estrogen receptor.
    Pal A; Ganguly A; Ghosh A; Yousuf M; Rathore B; Banerjee R; Adhikari S
    ChemMedChem; 2014 Apr; 9(4):727-32. PubMed ID: 24482362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Assembling Derivative of Hydrocortisone as Glucocorticoid Receptor-Targeted Nanotherapeutics for Synergistic, Combination Therapy against Colorectal Tumor.
    Sridharan K; Rathore B; Yousuf M; Reddy Rachamalla HK; Jinka S; Jaggarapu MMCS; Banerjee R
    Mol Pharm; 2021 Mar; 18(3):1208-1228. PubMed ID: 33371687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New cell cycle checkpoint pathways regulators with 2-Oxo-indoline scaffold as potential anticancer agents: Design, synthesis, biological activities and in silico studies.
    Abd El-Wahab HAA; Mansour HS; Ali AM; El-Awady R; Aboul-Fadl T
    Bioorg Chem; 2022 Mar; 120():105622. PubMed ID: 35091290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen receptor-mediated liposomal drug delivery for treating melanoma.
    Ganguly A; Rachamalla HKR; Bhattacharya D; Bhamidipati K; Pal A; Gora Ravuri H; Chakravarty S; Adhikari SS; Banerjee R
    J Drug Target; 2018; 26(5-6):481-493. PubMed ID: 29376759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Synthesis of New
    Farghaly TA; Pashameah RA; Bayazeed A; Al-Soliemy AM; Alsaedi AMR; Harras MF
    Med Chem; 2024; 20(1):63-77. PubMed ID: 37723960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma.
    Mohamed MF; Abdelmoniem AM; Elwahy AHM; Abdelhamid IA
    Curr Cancer Drug Targets; 2018; 18(4):372-381. PubMed ID: 28669339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Bioactivity Assessment of Novel Spiro Pyrazole-Oxindole Congeners Exhibiting Potent and Selective
    Abo-Salem HM; Nassrallah A; Soliman AAF; Ebied MS; Elawady ME; Abdelhamid SA; El-Sawy ER; Al-Sheikh YA; Aboul-Soud MAM
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32138244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirotriazoline oxindoles: A novel chemical scaffold with in vitro anticancer properties.
    Ribeiro CJA; Nunes RC; Amaral JD; Gonçalves LM; Rodrigues CMP; Moreira R; Santos MMM
    Eur J Med Chem; 2017 Nov; 140():494-509. PubMed ID: 28987608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting the antiproliferative potential of spiropyrazoline oxindoles in a human ovarian cancer cell line.
    Raposo LR; Silva A; Silva D; Roma-Rodrigues C; Espadinha M; Baptista PV; Santos MMM; Fernandes AR
    Bioorg Med Chem; 2021 Jan; 30():115880. PubMed ID: 33348171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer.
    Jinka S; Rachamalla HK; Bhattacharyya T; Sridharan K; Sekhar Jaggarapu MMC; Yakati V; Banerjee R
    Biomed Mater; 2021 Feb; 16(2):024105. PubMed ID: 33434900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and
    Eldehna WM; Al-Rashood ST; Al-Warhi T; Eskandrani RO; Alharbi A; El Kerdawy AM
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):270-285. PubMed ID: 33327806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of in vitro cytotoxic effects of triazol/spiroindolinequinazolinedione, triazol/indolin-3-thiosemicarbazone and triazol/thiazol-indolin-2-one conjugates.
    Nazari S; Safari F; Mamaghani MB; Bazgir A
    Daru; 2020 Dec; 28(2):591-601. PubMed ID: 32803690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives.
    Dey SK; Bose D; Hazra A; Naskar S; Nandy A; Munda RN; Das S; Chatterjee N; Mondal NB; Banerjee S; Saha KD
    PLoS One; 2013; 8(3):e58055. PubMed ID: 23472133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel spiropyrazoline oxindoles and evaluation of cytotoxicity in cancer cell lines.
    Monteiro Â; Gonçalves LM; Santos MM
    Eur J Med Chem; 2014 May; 79():266-72. PubMed ID: 24747063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents.
    Pathak A; Pandey V; Raj Pokharel Y; Devaraji V; Ali A; Haider K; Saad S; Dewangan RP; Siddiqui N; Shahar Yar M
    Bioorg Chem; 2021 Nov; 116():105358. PubMed ID: 34544029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy.
    Gupta AK; Bharadwaj M; Kumar A; Mehrotra R
    Top Curr Chem (Cham); 2017 Feb; 375(1):3. PubMed ID: 27943171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro targeting of colon cancer cells using spiropyrazoline oxindoles.
    Nunes RC; Ribeiro CJA; Monteiro Â; Rodrigues CMP; Amaral JD; Santos MMM
    Eur J Med Chem; 2017 Oct; 139():168-179. PubMed ID: 28800455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design and synthesis of conformationally constrained derivatives of methyl-piperidinopyrazole (MPP) with estrogen receptor (ER) antagonist activity.
    Ragab MA; Elagawany M; Daabees H; Ahmed AF; Awad EM; Billon C; Elgendy B; Abouzid KAM; Kassab SE
    Bioorg Chem; 2022 Feb; 119():105554. PubMed ID: 34923243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.